Expanded Hemodialysis with Theranova 500 Improves Dialysis Adequacy and Blunts Inflammation: A 24-Week Quasi-Randomized Trial.

J Clin Med · 2025 · PMC12733824 · PMID 41464753

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The Theranova group showed greater improvement across more quality of life items, at 52 of 80 measures (65%) compared to 47 of 80 measures (58%) in the Revaclear group; however, the observed difference in improvement rates did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.